Market Overview

Morgan Stanley Offers Pre-2Q Thoughts on Monsanto Company

Share:
Related MON
These Non-Tech Companies Are Investing In An AI Future
Benzinga's Top Upgrades, Downgrades For July 12, 2017
Exane Asset Management Buys Monsanto Co, Biogen Inc, Qiagen NV, Sells Citigroup Inc, W R Grace, ... (GuruFocus)

In a report published Thursday, Morgan Stanley analyst Vincent Andrews reiterated an Overweight rating and $150.00 price target on Monsanto Company (NYSE: MON).

In the report, Morgan Stanley noted, “F2Q buy side expectations appear below consensus but largely inline with our own due to a weather timing shift into F3Q. A modest bump to both the low and the high end of guidance is likely, but we do not anticipate a material guidance upgrade until F3Q reporting when all of the seed is planted.”

Monsanto Company closed on Wednesday at $111.72.

Latest Ratings for MON

DateFirmActionFromTo
Jul 2017JefferiesDowngradesBuyHold
Jun 2017SusquehannaDowngradesPositiveNeutral
Feb 2017RBC CapitalInitiates Coverage OnSector Perform

View More Analyst Ratings for MON
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Vincent AndrewsAnalyst Color Reiteration Analyst Ratings

 

Related Articles (MON)

View Comments and Join the Discussion!